Navigation Links
Goodwin Biotechnology Announces the Appointment of SooYoung S. Lee, PhD as Chief Operating Officer
Date:9/12/2013

PLANTATION, Fla., Sept. 12, 2013 /PRNewswire/ -- Goodwin Biotechnology, Inc.  announced a key appointment that is designed to position the company for the future. SooYoung Lee, PhD has returned to Goodwin Biotechnology as Chief Operating Officer. He will report to newly appointed CEO, Karl Pinto, and will oversee all aspects of Goodwin's Contract Manufacturing Operations.

SooYoung has had a distinguished career in the biological industry spanning several decades.  After earning his PhD in Biochemical Engineering at Cornell University, he held several  leadership positions at leading biopharmaceutical companies and CMO's such as SAIC – Frederick, Schering-Plough Research Institute, Wyeth – Lederle Vaccines, AppTec, Neose Technologies and Genencor. He also has extensive experience in international biotechnology operations, having established and served as the Director of the Biopharmaceutical Manufacturing Technology Center (BMTC) in Singapore, and as a Senior Member, he helped establish the International Vaccine Institute (IVI) in Seoul, Korea. 

"I am excited about the opportunity to team up with the dedicated staff at Goodwin Biotechnology," said SooYoung Lee, PhD.  "Since its inception in 1992, the company has a distinguished history and a great track record of providing quality Contract Development and Manufacturing services and GMP clinical material as the first comprehensive CMO focusing on cell culture-based biologics. Our goal is to continue working with our clients as a development and manufacturing partner to manufacture cGMP compliant clinical trial material in a timely and cost-effective manner. Being uniquely flexible in our client engagements and shortening the time from bench to clinic will have a critical impact on the success of our partners and ultimately benefit patients and their families." 

"SooYoung's experiences in process development, tech transfer and GMP manufacturing along with strategic planning and execution will help ensure the delivery of the highest quality services and products that are in compliance with current Good Manufacturing Practices (cGMP) to our clients, ranging from the smallest biotech start-ups to large biopharma companies," noted Karl Pinto. "With this significant addition, we are poised to take the company to new heights."

About Goodwin Biotechnology, Inc.

Goodwin Biotechnology is a world-class CMO that offers a Single Source Solution™ through partnerships with clients for cell line development or exploratory proof of concept projects through process development and cGMP contract manufacturing of monoclonal antibodies, recombinant proteins, vaccines and Antibody Drug Conjugates (ADCs) for early and late stage clinical trials. By working with GBI, our clients can enhance the value of their product candidates with clear development and manufacturing strategies as well as a road map to meet the highest quality product requirements from the milligram and gram range to kilogram quantities as the product candidates move along the clinical approval pathway in a cost-effective, timely, and cGMP compliant manner to enhance patients' lives. With over 20 years of experience as an independent contract manufacturer, GBI has worked as a strategic partner with companies of all sizes from small university spin-offs to major research institutes, government agencies and large, established and multi-national biopharmaceutical companies. Additional information may be found at www.GoodwinBio.com.

For more information on the process development and GMP manufacturing of biologics, please contact Goodwin Biotechnology:

Robin McCallum 
Business Development Manager 
(954) 327-9656  
RMcCallum@GoodwinBio.com


'/>"/>
SOURCE Goodwin Biotechnology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Goodwin Biotechnology Announces Process Development Sub-Contract for an Anthrax Vaccine
2. Goodwin Biotechnology is a Three-Category Winner in the 2012 CMO Leadership Awards
3. Jeannette R. Jakus, MD, MBA, Awarded American Academy of Dermatology Translational Biotechnology Fellowship
4. TWi Biotechnology Receives Patent Allowance for Its Lead Drug Candidate AC-201 in the United States
5. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
6. The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
7. ResearchMoz.us: Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
8. Platine Pharma Services et Indicia Biotechnology se rapprochent pour renforcer leur leadership en immunomonitoring
9. Sony Biotechnology Inc.s New Technology for Science Provides Researchers Results in Color
10. Plandai Biotechnology, Inc. Announces Formation Of New Entity To Develop Pharmaceutical Applications
11. Increased Dosage of Needle-Free Erectile Dysfunction Medication TriMix-gel Now Available through KRS Global Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, ... matching users with high quality water pipes within an ideal price range. The site ... was founded by two brothers, Nick and Mike Hunter, who use medical cannabis to ...
Breaking Medicine News(10 mins):